Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Colorectal Neoplasms × Control Groups × Clear all

Phase

Phase NA 6 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Colorectal Neoplasms 1

Interventions

Oncolytic Virotherapy 2 tucatinib 1 trifluridine tipiracil drug combination 1 tribenoside (combination) 1 tribenoside 1 trastuzumab deruxtecan 1 tipiracil 1 sotorasib 1 regorafenib 1 polyethylene glycol 400 1 penpulimab 1 palbociclib 1 montelukast 1 encorafenib 1 binimetinib 1 adagrasib 1 Trifluridine 1 Tobacco Use Cessation Devices 1 Tablets 1 Suppositories 1 Standard of Care 1 Specimen Handling 1 Polyethylene Glycols 1 Pentoxifylline 1 Panitumumab 1 Oxaliplatin 1 Nitrates 1 Neomycin 1 NK Cell Lectin-Like Receptor Subfamily K 1 Microscopy, Electron 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02304978 2025-12-26

TF

University Hospital, Lille

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡